Denali Therapeutics (DNLI) Financials: Revenue & Earnings

DNLI price $18.98 -0.23 -1.22%

Ticker
DNLI
Price
$18.98
Change
-0.23 -1.22%
Market cap ?
$3.03B
Beta ?
1.02
Sector
Healthcare
Industry
Biotechnology

Fair value

DNLI fair value $24.81. Price $18.98. Price is 23% below fair value.

Above fair value, but less expensive than usual. A smaller premium than on 74% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare DNLI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-0.32—12.22M
2026-08-06-0.68-0.513.60M2.15M
2026-05-07-0.69-0.73—2.57M
2026-02-26-0.73-0.75—3.08M
2025-11-06-0.74-0.76—2.86M
2025-08-11-0.72-0.74—5.64M
2025-05-06-0.78-0.71—2.97M
2025-02-27-0.67-0.75—12.75M
2024-11-06-0.63-0.60—11.62M
2024-08-01-0.59-0.68—12.51M
2024-05-07-0.68-0.67—14.02M
2024-02-27-0.86-0.82305.04M8.36M
2023-11-07-0.72-0.831.27M8.94M
2023-08-081.30-0.68294.12M13.46M
2023-05-08-0.80-0.7135.14M28.72M
2023-02-27-0.75-0.7810.28M13.12M
2022-11-03-0.84-0.833.56M17.02M
2022-08-08-0.48-0.5252.48M44.66M
2022-05-05-0.53-0.4742.14M33.36M
2022-02-28-0.62-0.4112.51M44.82M
2021-11-04-0.69-0.515.29M32.03M
2021-08-04-0.50-0.3722.94M22.94M
2021-05-03-0.58-0.377.92M5.77M
2021-02-251.910.01316.81M78.21M
2020-11-05-0.543.579.39M51.84M
2020-08-07-0.56-0.615.85M6.26M
2020-05-07-0.55-0.573.60M3.74M
2020-02-27-0.56-0.534.67M4.84M
2019-11-06-0.48-0.5313.60M15.87M
2019-08-06-0.61-0.464.20M3.16M
2019-05-08-0.41-0.374.21M4.10M
2019-03-120.79-0.11125.68M17.50M
2018-11-08-0.38-0.211.20M786.18K
2018-08-09-0.59-0.191.65M558.64K
2018-05-11-0.26-0.03641.00K73.96K
2018-03-19-0.74-0.20145.15M—
2017-12-08-0.32———
2017-09-30-0.27———
2017-03-31-2.36———
2016-12-31-2.15———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-04Chin Peter ScottSell1.65K$22.2936.87K
2026-09-02Thornberry NancySell10.82K$22.85247.33K
2026-09-02Thornberry NancySell615$23.7414.60K
2026-09-01Schuth Alexander O.Sell2.77K$23.4464.88K
2026-08-12Watts Ryan J.Sell32.22K——
2026-08-11Schuth Alexander O.Sell2.86K$25.0771.62K
2026-06-03FLATLEY JAY TBuy6.41K——
2026-06-03FLATLEY JAY TBuy19.23K$19.66377.98K
2026-06-03Klein Peter SBuy6.41K——
2026-06-03Klein Peter SBuy19.23K$19.66377.98K
2026-06-03Krognes Steve E.Buy6.41K——
2026-06-03Krognes Steve E.Buy19.23K$19.66377.98K
2026-06-03Schenkein David PBuy6.41K——
2026-06-03Schenkein David PBuy19.23K$19.66377.98K
2026-06-03Thornberry NancyBuy6.41K——
2026-06-03Thornberry NancyBuy19.23K$19.66377.98K
2026-06-03Van Hauwermeiren TimothyBuy19.23K$19.66377.98K
2026-06-03Van Hauwermeiren TimothyBuy6.41K——
2026-06-03Cook Jennifer E.Buy6.41K——
2026-06-03Cook Jennifer E.Buy19.23K$19.66377.98K
2026-06-03BAKER BROS. ADVISORS LPBuy6.41K——
2026-06-03BAKER BROS. ADVISORS LPBuy6.41K——
2026-06-03BAKER BROS. ADVISORS LPBuy19.23K$19.66377.98K
2026-06-03BAKER BROS. ADVISORS LPBuy19.23K$19.66377.98K
2026-04-10Chin Peter ScottOther0——
2026-04-10Chin Peter ScottOther0——
2026-04-10Chin Peter ScottOther63.80K$20.171.29M
2026-04-10Chin Peter ScottOther43.00K$22.31959.33K
2026-04-10Chin Peter ScottOther35.10K$24.81870.83K
2026-04-10Chin Peter ScottOther14.25K$80.031.14M
2026-04-10Chin Peter ScottOther13.00K$47.27614.51K
2026-04-10Chin Peter ScottOther10.25K$33.74345.83K
2026-04-10Chin Peter ScottOther32.90K$27.63909.03K
2026-04-10Chin Peter ScottOther44.75K$20.33909.77K
2026-04-10Chin Peter ScottOther40.65K$21.26864.22K
2026-01-06Watts Ryan J.Sell35.20K$16.50580.77K
2026-01-06Schuth Alexander O.Sell17.22K$16.50284.10K
2026-01-03Schuth Alexander O.Buy57.70K——
2026-01-03Schuth Alexander O.Buy173.10K$16.272.82M
2026-01-03Watts Ryan J.Buy78.96K——
2026-01-03Watts Ryan J.Buy236.88K$16.273.85M
2025-12-11BAKER BROS. ADVISORS LPBuy2.10M$0.0120.95K
2025-12-11BAKER BROS. ADVISORS LPBuy190.52K$0.011.91K
2025-11-04Van Hauwermeiren TimothyBuy31.90K$14.92475.90K
2025-11-04Van Hauwermeiren TimothyBuy10.63K——
2025-11-04Van Hauwermeiren TimothyOther0——
2025-09-03Watts Ryan J.Sell50.00K——
2025-08-13Ho CaroleSell806$14.6411.80K
2025-08-12Schuth Alexander O.Sell2.94K$13.5839.88K
2025-08-12Ho CaroleSell2.94K$13.5839.88K
2025-08-05Ho CaroleBuy44.66K$0.6830.37K
2025-08-05Ho CaroleSell44.66K$0.6830.37K
2025-07-09Watts Ryan J.Buy40.00K$5.28211.20K
2025-07-09Watts Ryan J.Buy455.28K$0.68309.59K
2025-07-09Watts Ryan J.Sell455.28K$0.68309.59K
2025-07-09Watts Ryan J.Sell495.28K$15.007.43M
2025-07-09Watts Ryan J.Sell40.00K$5.28211.20K
2025-06-03BAKER BROS. ADVISORS LPBuy10.56K——
2025-06-03BAKER BROS. ADVISORS LPBuy10.56K——
2025-06-03BAKER BROS. ADVISORS LPBuy31.70K$13.93441.51K
2025-06-03BAKER BROS. ADVISORS LPBuy31.70K$13.93441.51K
2025-06-03BAKER BROS. ADVISORS LPOther0——
2025-06-03BAKER BROS. ADVISORS LPOther0——
2025-06-03BAKER BROS. ADVISORS LPOther23.90M$0.01239.01K
2025-06-03BAKER JULIANOther0——
2025-06-03Cook Jennifer E.Buy6.04K——
2025-06-03Cook Jennifer E.Buy18.11K$13.93252.29K
2025-06-03FLATLEY JAY TBuy18.11K$13.93252.29K
2025-06-03FLATLEY JAY TBuy6.04K——
2025-06-03Klein Peter SBuy6.04K——
2025-06-03Klein Peter SBuy18.11K$13.93252.29K
2025-06-03Krognes Steve E.Buy6.04K——
2025-06-03Krognes Steve E.Buy18.11K$13.93252.29K
2025-06-03Schenkein David PBuy18.11K$13.93252.29K
2025-06-03Schenkein David PBuy6.04K——
2025-06-03Thornberry NancyBuy6.04K——
2025-06-03Thornberry NancyBuy18.11K$13.93252.29K
2025-06-03Tessier-Lavigne MarcBuy6.04K——
2025-06-03Tessier-Lavigne MarcBuy18.11K$13.93252.29K
2025-01-07Ho CaroleSell2.91K$20.8160.49K
2025-01-07Schuth Alexander O.Sell2.91K$20.8160.49K
2025-01-07Watts Ryan J.Sell7.65K$20.81159.20K
2025-01-07Krognes Steve E.Sell3.34K$20.8169.48K
2025-01-06Ho CaroleSell12.26K$20.22247.80K
2025-01-06Schuth Alexander O.Sell12.26K$20.22247.80K
2025-01-06Watts Ryan J.Sell29.27K$20.22591.76K
2025-01-03Watts Ryan J.Buy54.18K——
2025-01-03Watts Ryan J.Buy162.54K$21.263.46M
2025-01-03Schuth Alexander O.Buy54.18K——
2025-01-03Schuth Alexander O.Buy162.54K$21.263.46M
2025-01-03Ho CaroleBuy54.18K——
2025-01-03Ho CaroleBuy162.54K$21.263.46M
2025-01-02SATO VICKI LSell3.08K$20.9164.40K
2024-12-31Krognes Steve E.Sell30.00K$20.25607.50K
2024-12-27Schuth Alexander O.Buy6.71K$5.2835.42K
2024-12-27Schuth Alexander O.Sell6.71K$5.2835.42K
2024-11-25Ho CaroleBuy17.84K$0.6812.13K
2024-11-25Ho CaroleSell17.84K$0.6812.13K
2024-11-22Schuth Alexander O.Buy20.52K$0.6813.95K
2024-11-22Schuth Alexander O.Sell20.52K$0.6813.95K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 302, holders +20 vs prior quarter. Ownership 84.07%.

HolderSharesChangeChange %Value
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.16.18M7.66M+89.91%416.12M
BLACKROCK, INC.14.03M991.98K+7.61%360.76M
BAILLIE GIFFORD & CO11.96M-106.25K-0.88%307.62M
STATE STREET CORP7.05M777.30K+12.39%181.31M
TEMASEK HOLDINGS (PRIVATE) LTD7.01M00.00%180.37M
VANGUARD PORTFOLIO MANAGEMENT LLC6.48M356.90K+5.83%166.59M
VANGUARD CAPITAL MANAGEMENT LLC6.28M127.77K+2.08%161.41M
FMR LLC4.54M-39.54K-0.86%116.66M
GOLDMAN SACHS GROUP INC4.16M-251.36K-5.70%106.89M
GEODE CAPITAL MANAGEMENT, LLC3.97M246.23K+6.61%102.21M
HOLOCENE ADVISORS, LP3.91M709.80K+22.21%100.44M
BAKER BROS. ADVISORS LP3.73M2.64K+0.07%96.05M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC3.16M-1.27M-28.66%81.33M
PRICE T ROWE ASSOCIATES INC /MD/3.14M672.00K+27.27%80.66M
UBS GROUP AG3.12M549.25K+21.36%80.26M
DIMENSIONAL FUND ADVISORS LP2.86M168.43K+6.26%73.58M
NORGES BANK2.82M2.82MNew72.65M
PICTET ASSET MANAGEMENT HOLDING SA2.79M232.34K+9.08%71.89M
CAPITAL RESEARCH GLOBAL INVESTORS2.57M51.23K+2.04%65.99M
FISHER ASSET MANAGEMENT, LLC2.41M-22.73K-0.93%62.09M
ALLIANCEBERNSTEIN L.P.2.98M91.19K+3.15%57.31M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.2.21M2.09M+1828.21%56.80M
CASDIN CAPITAL, LLC2.04M205.00K+11.14%52.60M
CRESTLINE MANAGEMENT, L.P.1.91M-300.00K-13.57%49.14M
PRINCIPAL FINANCIAL GROUP INC1.42M-58.40K-3.95%36.52M

Earnings and financials

Denali Therapeutics Inc. (DNLI) trades at $18.98, with a market cap of $3.03B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Denali Therapeutics (DNLI) Financials: Revenue & Earnings

DNLI$18.98-0.23 -1.22%

$3.03B

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History